JIR
ARA

James Investment Research’s American Renal Associates Holdings, Inc ARA Stock Holding History

James Investment Research’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-295
Closed -$3K – 938
2018
Q4 		$3K Buy
+295
New +$5.03K ﹤0.01% 761

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

James Investment Research's ARA Position: Q1 2019 in Review

James Investment Research sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2019, closing a stake of 295 shares — an estimated $3K sold.

James Investment Research first reported a position in ARA in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 68 funds tracked by Wall St. Rank hold ARA as of Q1 2019.

  • James Investment Research reported no remaining American Renal Associates Holdings, Inc position as of Q1 2019 after selling out during the quarter.
  • James Investment Research sold 295 American Renal Associates Holdings, Inc shares in Q1 2019, an estimated $3K.
  • James Investment Research first reported a position in American Renal Associates Holdings, Inc in Q4 2018 and held it in 1 quarter.
  • James Investment Research's American Renal Associates Holdings, Inc position peaked at $3K in Q4 2018.
  • 68 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2019.

Based on James Investment Research's 13F filing for Q1 2019, filed 26 Apr 2019.